Who is sponsoring NCT05661994?

NCT05661994 is sponsored by Amasya University.

What drugs are being tested in NCT05661994?

Interventions in NCT05661994: Omega-3 fatty acid supplementation.

What condition does NCT05661994 study?

NCT05661994 studies Coronary Artery Disease.

Is NCT05661994 still recruiting?

NCT05661994 is currently completed. Last updated 22 December 2022.

Last reviewed 2022-12-22 · How we verify

NCT05661994

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Omega-3 Supplementation on Serum Fetuin-A Levels

Completed NA Last updated 22 December 2022

What this trial tests

NA trial testing Omega-3 fatty acid supplementation in Coronary Artery Disease in 34 participants. Completed in 8 April 2022.

Timeline

18 December 2020

Primary endpoint
11 October 2021

8 April 2022

Quick facts

Lead sponsor	Amasya University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	34
Start date	18 December 2020
Primary completion	11 October 2021
Estimated completion	8 April 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Omega-3 fatty acid supplementation

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

Amasya University

Who can join

Adults 35 to 75, male only, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background and aims: One of the investigated possible modulators of serum fetuin-A, associated with the risk of developing coronary artery disease (CAD), is omega-3 fatty acids (FAs). This study aims to evaluate the effects of omega-3 FA supplementation on serum fetuin-A concentration in patients with CAD. Methods: The study was carried out on 34 male volunteer patients aged 35-75 years, newly diagnosed with CAD by conventional coronary angiography. Patients with CAD were divided into the "Omega-3 Group (n:16)" and "Control Group (n:18)". Low-fat diet principles were explained to both groups at baseline. While 1.560 mg/day omega-3 FA supplementation was given to the patients in the omega-3 group for eight weeks, but not in the control group. Food intake was recorded using six-day food records.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of Omega-3 Fatty Acid Supplementation on Serum Fetuin-A Levels in Patients With Coronary Artery Disease.
Icer MA, Yıldıran H, Sahinarslan A, Topal S. · · 2025 · PMID 40538988 · DOI 10.1002/fsn3.70460

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Amasya University trials

Trials by the same sponsor.

NCT07512999 — The Effect of Using Nature Sounds and Virtual Reality During the Non-Stress Test · NA · not yet recruiting
NCT07510555 — The Effect of a Mindfulness-Based Stress Reduction Program Applied to Nulliparous Pregnant Women · NA · not yet recruiting
NCT07485790 — The Effects of Yoga on Pregnant Women · NA · recruiting
NCT07360392 — BiFeS vs. iPACK in Postoperative Knee Arthroplasty Analgesia · NA · not yet recruiting
NCT07343414 — Effect of Anesthesia Technique on Surgical View in Shoulder Arthroscopy · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05661994 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Amasya University
Last refreshed: 22 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05661994.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing